Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare
Rein Therapeutics Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Rein Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 7.2M, a 7.16% decrease year-over-year.
- Rein Therapeutics Inc. total liabilities for 2025 were 7.2M, a 7.16% decrease from 2024.
- Rein Therapeutics Inc. total liabilities for 2024 were 7.8M, a 1.13% increase from 2023.
- Rein Therapeutics Inc. total liabilities for 2023 were 7.7M, a 127.87% increase from 2022.
- Rein Therapeutics Inc. total liabilities for 2022 were 3.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Rein Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $8 |
| 2023 | $8 |
| 2022 | $3 |
| 2021 | $5 |
| 2020 | $4 |
| 2019 | $10 |
| 2018 | $11 |
| 2017 | $5 |
| 2016 | $4 |
| Rein Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $7 |
| 2024-12-31 | $8 |
| 2023-12-31 | $8 |
| 2022-12-31 | $3 |
| 2021-12-31 | $5 |
| 2020-12-31 | $4 |
| 2019-12-31 | $10 |
| 2018-12-31 | $11 |
| 2017-12-31 | $5 |
| 2016-12-31 | $4 |
Rein Therapeutics Inc. Total Liabilities — FAQ
Rein Therapeutics Inc. (RNTX) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNTX's total liabilities history?
The chart and table above show Rein Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.